Use of traditional medicine in middle-income countries a WHO-SAGE study

It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of T...

Full description

Saved in:
Bibliographic Details
Published inHealth policy and planning Vol. 31; no. 8; pp. 984 - 991
Main Authors Oyebode, Oyinlola, Kandala, Ngianga-Bakwin, Chilton, Peter J, Lilford, Richard J
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.10.2016
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine. Il est souvent dit dans la littérature scientifique, les rapports officiels et la presse que 80% des populations asiatiques et africaines ont recours à la médecine traditionnelle (MT) pour satisfaire leurs besoins en matière de soins de santé; toutefois, cette donnée statistique n’a été diffusée pour la première fois qu’en 1983. La présente étude vise à mettre à jour les connaissances sur la prévalence du recours à la MT et les caractéristiques de ceux qui y ont accès, afin d’éclairer les décideurs du secteur de la santé puisque les pays cherchent à se conformer à la stratégie 2014-23 de l ’OMS relative à la MT, et à exploiter la MT au profit de la santé des populations. La prévalence du recours déclaré à la MT a été étudiée chez 35 334 participants du programme OMS-SAGE, interrogés entre 2007 et 2010. On a procédé à une comparaison des personnes qui ont recours à la MT avec celles qui utilisent les soins de santé modernes par le biais d’analyses univariées et multivariées. Les caractéristiques étudiées comprenaient l’âge, le sexe, la géographie (urbaine/rurale), le quintile de revenu, l’éducation, l’état de santé déclaré et la présence de maladies chroniques spécifiques. Cette étude a révélé que le recours à la MT était plus courant en Inde: 11,7% des personnes ont déclaré que la MT était leur source de soins la plus courante au cours des 3 années précédentes; 19,0% ont déclaré avoir eu recours à la MT au cours des 12 mois précédents. En revanche en Chine, au Ghana, au Mexique, en Russie et en Afrique du Sud, <3% ont déclaré la MT comme leur source de soins la plus courante; et<2% ont déclaré avoir eu recours à la MT l’année précédente au Ghana, au Mexique, en Russie et en Afrique du Sud. En analyse univariée, les participants les plus pauvres, les moins instruits et ceux vivant dans les zones rurales étaient plus susceptibles de recourir à la MT. Dans l’analyse multivariée du cas de la Chine, la ruralité, le mauvais état de santé déclaré et la présence d’arthrite ont été associés au recours à la MT; alors que les cas diagnostiqués de diabète, d’hypertension et de cataracte étaient moins fréquents chez les usagers de la MT. Au Ghana et en Inde, le faible revenu, la dépression et l’hypertension ont été associés au recours à la MT. En conclusion, le recours à la MT est moins fréquent qu’on ne l’affirme souvent. Il peut s’avérer inutile, et peut-être futile, de chercher à satisfaire les besoins sanitaires de la population par le biais de la MT lorsque ces populations ont de plus en plus recours à la médecine moderne. Con frecuencia se afirma en la literatura científica, en los informes oficiales y en la prensa que el 80% de la población asiática y africana utiliza la medicina tradicional (MT) para satisfacer sus necesidades de cuidado de la salud; sin embargo, esta estadística se reportó por primera vez en 1983. Este estudio tuvo como objetivo actualizar los conocimientos de la prevalencia del uso de la MT y las características de las personas que acceden a ella, para informar a los formuladores de política de salud a medida que los países buscan cumplir la estrategia de la OMS MT 2014-23 y aprovechar la MT para la salud de la población. La prevalencia del uso informado de la MT se estudió en 35,334 participantes de la OMS-SAGE (Grupo Estratégico Consejero de Expertos), encuestados en 2007-10. Los usuarios de la MT se compararon con los usuarios del cuidado de la salud moderno en los análisis univariantes y multivariantes. Las características examinadas incluyeron edad, sexo, geografía (urbano/rural), quintil de ingreso, educación, percepción de salud y presencia de enfermedades crónicas específicas. Este estudio encontró que el uso de la MT era más alto en la India, el 11.7% de las personas informaron que su fuente más frecuente de cuidado durante los 3 años anteriores fue la MT; el 19.0% reportó el uso de la MT en los 12 meses anteriores. En contraste <3% mencionó la MT como su más frecuente fuente de cuidado en China, Ghana, México, Rusia y Sudáfrica; y <2% reportó el uso de MT en el año anterior en Ghana, México, Rusia y Sudáfrica. En los análisis univariantes, los más pobres, los menos educados y los participantes rurales eran más propensos a ser usuarios de la MT. En el análisis multivariante de China, la ruralidad, los autoinformes de salud pobre y la presencia de la artritis se asociaron con el uso de la MT; mientras que el diagnóstico de diabetes, hipertensión y cataratas eran menos prevalentes en los usuarios de la MT. En Ghana y en la India, los ingresos más bajos, la depresión y la hipertensión fueron asociados con el uso de la MT. En conclusión, el uso de la MT es menos frecuente de lo que comúnmente se reporta. Puede ser innecesario, y hasta inútil, tratar de emplear la MT para las necesidades de salud de la población cuando las poblaciones están utilizando cada vez más la medicina moderna. 科学文献、官方报告和出版物经常提及80%亚洲和非洲人口 使用传统药物满足他们的医疗需求;但是该数据最初于1983 年提出。本文旨在更新传统药物使用普及性的知识以及使用 人群的特性, 从而提醒医疗政策制定者力求实现世界卫生组织 2014-2023传统药物战略和控制传统药物对人口健康的影响。 披露的传统药物使用的普及性来自对2007-2010年35334名世 界卫生组织——全球老龄化和成人健康组织调查参与者的调 查结果。传统药物使用者与现代医疗使用者在单因素和多因 素分析中进行比较。调查的特征包括年龄、性别、地区性 (城市/乡村) 、收入等级、教育水平、自评健康状况、是否 存在特殊慢性疾病。本研究发现传统药物在印度使用率最高, 11.7%的被调查者表明他们在近3年最常用的医疗方式是传统 药物;19.0%的人回答他们在过去12个月使用过传统药物。相 反, 在中国、加纳、墨西哥、俄罗斯和南非, 低于3%的人将传 统药物当作他们最常用的医疗方式;在加纳、墨西哥、俄罗 斯和南非低于2%的人在过去1年使用传统药物。在多变量分 析中, 较贫困、较低教育水平和乡村地区的被调查者更可能使 用传统药物。在中国多变量分析中, 乡村地区、自评健康条件 较差和存在关节炎的被调查者与传统药物使用相关;然而糖 尿病、高血压和白内障患者更不可能成为传统药物使用者。 在加纳和印度, 较低收入人群、抑郁症和高血压患者更可能使 用传统药物。总之, 传统药物使用没有通常报告中描绘的那样 普遍。当人们更多使用现代药物的时候, 或许没有必要为人口 健康寻求如何探索利用传统药物。
AbstractList It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine.
It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014-23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007-10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine.It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014-23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007-10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine.
It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine. Il est souvent dit dans la littérature scientifique, les rapports officiels et la presse que 80% des populations asiatiques et africaines ont recours à la médecine traditionnelle (MT) pour satisfaire leurs besoins en matière de soins de santé; toutefois, cette donnée statistique n’a été diffusée pour la première fois qu’en 1983. La présente étude vise à mettre à jour les connaissances sur la prévalence du recours à la MT et les caractéristiques de ceux qui y ont accès, afin d’éclairer les décideurs du secteur de la santé puisque les pays cherchent à se conformer à la stratégie 2014-23 de l ’OMS relative à la MT, et à exploiter la MT au profit de la santé des populations. La prévalence du recours déclaré à la MT a été étudiée chez 35 334 participants du programme OMS-SAGE, interrogés entre 2007 et 2010. On a procédé à une comparaison des personnes qui ont recours à la MT avec celles qui utilisent les soins de santé modernes par le biais d’analyses univariées et multivariées. Les caractéristiques étudiées comprenaient l’âge, le sexe, la géographie (urbaine/rurale), le quintile de revenu, l’éducation, l’état de santé déclaré et la présence de maladies chroniques spécifiques. Cette étude a révélé que le recours à la MT était plus courant en Inde: 11,7% des personnes ont déclaré que la MT était leur source de soins la plus courante au cours des 3 années précédentes; 19,0% ont déclaré avoir eu recours à la MT au cours des 12 mois précédents. En revanche en Chine, au Ghana, au Mexique, en Russie et en Afrique du Sud, <3% ont déclaré la MT comme leur source de soins la plus courante; et<2% ont déclaré avoir eu recours à la MT l’année précédente au Ghana, au Mexique, en Russie et en Afrique du Sud. En analyse univariée, les participants les plus pauvres, les moins instruits et ceux vivant dans les zones rurales étaient plus susceptibles de recourir à la MT. Dans l’analyse multivariée du cas de la Chine, la ruralité, le mauvais état de santé déclaré et la présence d’arthrite ont été associés au recours à la MT; alors que les cas diagnostiqués de diabète, d’hypertension et de cataracte étaient moins fréquents chez les usagers de la MT. Au Ghana et en Inde, le faible revenu, la dépression et l’hypertension ont été associés au recours à la MT. En conclusion, le recours à la MT est moins fréquent qu’on ne l’affirme souvent. Il peut s’avérer inutile, et peut-être futile, de chercher à satisfaire les besoins sanitaires de la population par le biais de la MT lorsque ces populations ont de plus en plus recours à la médecine moderne. Con frecuencia se afirma en la literatura científica, en los informes oficiales y en la prensa que el 80% de la población asiática y africana utiliza la medicina tradicional (MT) para satisfacer sus necesidades de cuidado de la salud; sin embargo, esta estadística se reportó por primera vez en 1983. Este estudio tuvo como objetivo actualizar los conocimientos de la prevalencia del uso de la MT y las características de las personas que acceden a ella, para informar a los formuladores de política de salud a medida que los países buscan cumplir la estrategia de la OMS MT 2014-23 y aprovechar la MT para la salud de la población. La prevalencia del uso informado de la MT se estudió en 35,334 participantes de la OMS-SAGE (Grupo Estratégico Consejero de Expertos), encuestados en 2007-10. Los usuarios de la MT se compararon con los usuarios del cuidado de la salud moderno en los análisis univariantes y multivariantes. Las características examinadas incluyeron edad, sexo, geografía (urbano/rural), quintil de ingreso, educación, percepción de salud y presencia de enfermedades crónicas específicas. Este estudio encontró que el uso de la MT era más alto en la India, el 11.7% de las personas informaron que su fuente más frecuente de cuidado durante los 3 años anteriores fue la MT; el 19.0% reportó el uso de la MT en los 12 meses anteriores. En contraste <3% mencionó la MT como su más frecuente fuente de cuidado en China, Ghana, México, Rusia y Sudáfrica; y <2% reportó el uso de MT en el año anterior en Ghana, México, Rusia y Sudáfrica. En los análisis univariantes, los más pobres, los menos educados y los participantes rurales eran más propensos a ser usuarios de la MT. En el análisis multivariante de China, la ruralidad, los autoinformes de salud pobre y la presencia de la artritis se asociaron con el uso de la MT; mientras que el diagnóstico de diabetes, hipertensión y cataratas eran menos prevalentes en los usuarios de la MT. En Ghana y en la India, los ingresos más bajos, la depresión y la hipertensión fueron asociados con el uso de la MT. En conclusión, el uso de la MT es menos frecuente de lo que comúnmente se reporta. Puede ser innecesario, y hasta inútil, tratar de emplear la MT para las necesidades de salud de la población cuando las poblaciones están utilizando cada vez más la medicina moderna. 科学文献、官方报告和出版物经常提及80%亚洲和非洲人口 使用传统药物满足他们的医疗需求;但是该数据最初于1983 年提出。本文旨在更新传统药物使用普及性的知识以及使用 人群的特性, 从而提醒医疗政策制定者力求实现世界卫生组织 2014-2023传统药物战略和控制传统药物对人口健康的影响。 披露的传统药物使用的普及性来自对2007-2010年35334名世 界卫生组织——全球老龄化和成人健康组织调查参与者的调 查结果。传统药物使用者与现代医疗使用者在单因素和多因 素分析中进行比较。调查的特征包括年龄、性别、地区性 (城市/乡村) 、收入等级、教育水平、自评健康状况、是否 存在特殊慢性疾病。本研究发现传统药物在印度使用率最高, 11.7%的被调查者表明他们在近3年最常用的医疗方式是传统 药物;19.0%的人回答他们在过去12个月使用过传统药物。相 反, 在中国、加纳、墨西哥、俄罗斯和南非, 低于3%的人将传 统药物当作他们最常用的医疗方式;在加纳、墨西哥、俄罗 斯和南非低于2%的人在过去1年使用传统药物。在多变量分 析中, 较贫困、较低教育水平和乡村地区的被调查者更可能使 用传统药物。在中国多变量分析中, 乡村地区、自评健康条件 较差和存在关节炎的被调查者与传统药物使用相关;然而糖 尿病、高血压和白内障患者更不可能成为传统药物使用者。 在加纳和印度, 较低收入人群、抑郁症和高血压患者更可能使 用传统药物。总之, 传统药物使用没有通常报告中描绘的那样 普遍。当人们更多使用现代药物的时候, 或许没有必要为人口 健康寻求如何探索利用传统药物。
Author Kandala, Ngianga-Bakwin
Oyebode, Oyinlola
Lilford, Richard J
Chilton, Peter J
Author_xml – sequence: 1
  givenname: Oyinlola
  surname: Oyebode
  fullname: Oyebode, Oyinlola
– sequence: 2
  givenname: Ngianga-Bakwin
  surname: Kandala
  fullname: Kandala, Ngianga-Bakwin
– sequence: 3
  givenname: Peter J
  surname: Chilton
  fullname: Chilton, Peter J
– sequence: 4
  givenname: Richard J
  surname: Lilford
  fullname: Lilford, Richard J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27033366$$D View this record in MEDLINE/PubMed
BookMark eNqFkb1P3TAUxS1EVR7QsWNRpC5dAtcfsZOlUoWgICF1gdlynJvip8R-2Emr9q_HkAeiSKiD5cG_e3zuOftk1wePhHykcEyh4Se3aDZhOLF_fwNjO2RFhYSSMa52yQqYrEsKNeyR_ZTWAFQIUb0ne0wB51zKFZE3CYvQF1M0nZtc8GYoRuycdR4L54vRdd2ApfM2jFjYMPspOkyH5F1vhoQftvcBuTk_uz69KK9-fL88_XZV2gr4VErbQ2-62iICtr2qmQRpWymwga6vatZ0sgfgppGtqFhruEWDorKNwnyAH5Cvi-5mbrMti_l7M-hNdKOJf3QwTv_74t2t_hl-6QooV0plgS9bgRjuZkyTHl2yOAzGY5iTpjWtOWdU8Yx-foWuwxxzIEkzwSlQqR6po5eOnq08RZoBvgA2hpQi9tq6yTxEmw26QVPQD8XppTi9FJenyldTT8Jv8du9wrz5L_ppQddpCvEZFnUFDZXA7wERfbU7
CitedBy_id crossref_primary_10_29392_001c_13653
crossref_primary_10_1016_j_sajb_2024_04_016
crossref_primary_10_1080_17525098_2023_2252913
crossref_primary_10_60084_hjas_v2i2_208
crossref_primary_10_60084_mp_v1i1_24
crossref_primary_10_36106_paripex_2510301
crossref_primary_10_1007_s00508_020_01625_w
crossref_primary_10_1186_s12906_023_04229_9
crossref_primary_10_33084_bjop_v5i1_2968
crossref_primary_10_1080_10520295_2022_2147218
crossref_primary_10_1002_pan3_10249
crossref_primary_10_1155_2021_5537597
crossref_primary_10_5897_AJBR2021_1134
crossref_primary_10_3390_ijms19010263
crossref_primary_10_1155_2021_9991146
crossref_primary_10_1155_2023_2848198
crossref_primary_10_3389_fphar_2021_629935
crossref_primary_10_1007_s44338_024_00027_w
crossref_primary_10_1002_acr_23742
crossref_primary_10_1186_s12906_023_03889_x
crossref_primary_10_1080_14620316_2022_2046508
crossref_primary_10_1007_s10725_022_00818_9
crossref_primary_10_22270_jddt_v14i12_6916
crossref_primary_10_1007_s42250_020_00195_8
crossref_primary_10_4103_jras_jras_166_22
crossref_primary_10_1002_ptr_8084
crossref_primary_10_1007_s13596_021_00607_1
crossref_primary_10_1080_13549839_2020_1802410
crossref_primary_10_1287_isre_2019_0836
crossref_primary_10_51483_AFJPS_3_1_2023_14_30
crossref_primary_10_1111_tmi_13541
crossref_primary_10_51754_cusbed_1003634
crossref_primary_10_1089_omi_2018_0074
crossref_primary_10_3390_pharmaceutics14051072
crossref_primary_10_1016_j_jep_2024_118913
crossref_primary_10_1017_S0266467421000341
crossref_primary_10_1016_j_jksus_2023_102899
crossref_primary_10_1016_j_scitotenv_2021_146431
crossref_primary_10_4103_ijcfm_ijcfm_65_22
crossref_primary_10_1371_journal_pone_0276325
crossref_primary_10_1016_j_phymed_2018_08_013
crossref_primary_10_52711_2231_5713_2024_00035
crossref_primary_10_1186_s12906_024_04368_7
crossref_primary_10_1080_13880209_2021_1967410
crossref_primary_10_3390_jox13010007
crossref_primary_10_1155_2020_1543831
crossref_primary_10_17584_rcch_2023v17i1_15527
crossref_primary_10_25259_IJMS_285_2020
crossref_primary_10_1371_journal_pone_0313064
crossref_primary_10_1155_2020_1263702
crossref_primary_10_2174_1574885518666230719125554
crossref_primary_10_3390_biology9100313
crossref_primary_10_1007_s11904_022_00602_4
crossref_primary_10_3390_ijms24108918
crossref_primary_10_3390_md22070304
crossref_primary_10_1016_j_ijcard_2021_06_027
crossref_primary_10_1186_s12906_022_03692_0
crossref_primary_10_1055_s_0040_1712757
crossref_primary_10_1016_j_sajb_2019_06_035
crossref_primary_10_1002_jdd_13873
crossref_primary_10_1016_j_heliyon_2023_e19370
crossref_primary_10_1016_j_hermed_2018_06_001
crossref_primary_10_3390_plants13030453
crossref_primary_10_1177_09603271221126487
crossref_primary_10_7759_cureus_64074
crossref_primary_10_1016_j_ajp_2021_102975
crossref_primary_10_2174_0113892037307940240606075208
crossref_primary_10_1155_2018_1903629
crossref_primary_10_1590_1678_4685_gmb_2020_0371
crossref_primary_10_1186_s43088_021_00116_9
crossref_primary_10_1016_j_tfp_2023_100462
crossref_primary_10_1016_j_sajb_2024_10_024
crossref_primary_10_1007_s10722_023_01720_7
crossref_primary_10_1016_j_pce_2022_103232
crossref_primary_10_1016_j_bcab_2024_103374
crossref_primary_10_1016_j_puhe_2019_11_017
crossref_primary_10_3390_antibiotics14030293
crossref_primary_10_4103_bjhs_bjhs_52_20
crossref_primary_10_1007_s11756_021_00932_5
crossref_primary_10_1055_a_2044_9129
crossref_primary_10_1016_j_drup_2020_100695
crossref_primary_10_1016_j_sajb_2025_01_027
crossref_primary_10_3390_ijerph14070737
crossref_primary_10_1186_s13020_021_00491_6
crossref_primary_10_1007_s13596_020_00501_2
crossref_primary_10_1186_s12961_024_01166_y
crossref_primary_10_1016_j_eujim_2023_102316
crossref_primary_10_1186_s12981_023_00537_9
crossref_primary_10_1016_j_aimed_2020_11_002
crossref_primary_10_3389_fphar_2025_1475297
crossref_primary_10_1007_s00520_024_09017_w
crossref_primary_10_4155_fsoa_2017_0124
crossref_primary_10_1136_bmjopen_2021_054142
crossref_primary_10_1177_15404153241291747
crossref_primary_10_3389_fnut_2021_661455
crossref_primary_10_1093_inthealth_ihz077
crossref_primary_10_1016_j_sciaf_2019_e00108
crossref_primary_10_1371_journal_pone_0308879
crossref_primary_10_1007_s11356_020_10018_5
crossref_primary_10_1155_2019_6587150
crossref_primary_10_3390_app12157493
crossref_primary_10_3390_nu16203496
crossref_primary_10_1016_j_jep_2021_114419
crossref_primary_10_1080_00450618_2016_1273387
crossref_primary_10_1136_bmjopen_2019_029958
crossref_primary_10_33084_bjop_v6i3_4239
crossref_primary_10_3390_biochem1030017
crossref_primary_10_1016_j_cegh_2021_100880
crossref_primary_10_1016_j_heliyon_2024_e38885
crossref_primary_10_1007_s00210_023_02496_4
crossref_primary_10_1186_s12906_021_03247_9
crossref_primary_10_1016_j_chnaes_2022_07_011
crossref_primary_10_1007_s12639_023_01572_z
crossref_primary_10_1016_j_phymed_2018_06_007
crossref_primary_10_1007_s10389_020_01343_7
crossref_primary_10_1016_j_jep_2021_114550
crossref_primary_10_1039_D3RA06831E
crossref_primary_10_1016_j_hermed_2023_100698
crossref_primary_10_1016_j_intimp_2022_109508
crossref_primary_10_1016_j_heliyon_2023_e15938
crossref_primary_10_1016_j_procbio_2024_07_007
crossref_primary_10_51847_LgpNH7eJuy
crossref_primary_10_1016_j_jff_2020_104220
crossref_primary_10_1155_2021_3320325
crossref_primary_10_1007_s12115_024_01032_1
crossref_primary_10_1002_cbdv_202201098
crossref_primary_10_1155_2020_6636766
crossref_primary_10_1186_s12889_020_09479_7
crossref_primary_10_1186_s12906_024_04666_0
crossref_primary_10_1155_2022_8397250
crossref_primary_10_1007_s12687_022_00614_y
crossref_primary_10_31083_j_fbl2903111
crossref_primary_10_5897_JMPR2021_7203
crossref_primary_10_1515_chem_2022_0176
crossref_primary_10_3390_ijms252312960
crossref_primary_10_1007_s10459_020_09976_9
crossref_primary_10_1016_j_aimed_2019_02_002
crossref_primary_10_3390_geriatrics4030049
crossref_primary_10_3390_life13020411
crossref_primary_10_1155_2020_8516105
crossref_primary_10_1186_s43088_019_0015_y
crossref_primary_10_1186_s12906_021_03432_w
crossref_primary_10_1111_nmo_14065
crossref_primary_10_3390_app13053266
crossref_primary_10_3389_fpubh_2023_1104510
crossref_primary_10_1007_s43450_022_00263_9
crossref_primary_10_1016_j_heliyon_2020_e04894
crossref_primary_10_4103_ijar_ijar_20_23
crossref_primary_10_1016_j_chnaes_2022_03_002
crossref_primary_10_18865_1669
crossref_primary_10_18311_jnr_2023_32242
crossref_primary_10_1136_bmjgh_2018_000895
crossref_primary_10_1177_10781552211040725
crossref_primary_10_3390_ijerph18168638
crossref_primary_10_1186_s13002_024_00723_7
crossref_primary_10_1080_2314808X_2022_2045455
crossref_primary_10_1016_j_jep_2023_117333
crossref_primary_10_1002_wmh3_501
crossref_primary_10_1016_j_hermed_2022_100548
crossref_primary_10_1080_10253890_2019_1709435
crossref_primary_10_1016_S1470_2045_21_00720_8
crossref_primary_10_3390_ijms24020915
crossref_primary_10_3889_oamjms_2022_8637
crossref_primary_10_1007_s12010_023_04783_5
crossref_primary_10_3390_biomedicines7030063
crossref_primary_10_1155_2022_7621599
crossref_primary_10_3831_KPI_2022_25_3_209
crossref_primary_10_1016_j_heliyon_2022_e10790
crossref_primary_10_12688_aasopenres_12955_1
crossref_primary_10_2196_25703
crossref_primary_10_1055_s_0043_1760832
crossref_primary_10_1186_s13643_023_02398_9
crossref_primary_10_3390_cancers12082064
crossref_primary_10_4103_ijptr_ijptr_16_23
crossref_primary_10_1038_s41598_024_77796_7
crossref_primary_10_5812_jjcdc_96058
crossref_primary_10_1016_j_obmed_2022_100419
crossref_primary_10_14720_abs_67_1_18390
crossref_primary_10_3390_agronomy14061269
crossref_primary_10_1016_j_jksus_2023_103038
crossref_primary_10_1111_maq_12467
crossref_primary_10_1186_s12906_020_03195_w
crossref_primary_10_1016_j_yrtph_2022_105188
crossref_primary_10_1016_j_ajp_2020_102284
crossref_primary_10_7759_cureus_28767
crossref_primary_10_4103_jehp_jehp_704_21
crossref_primary_10_1093_trstmh_traa135
crossref_primary_10_1186_s12889_023_15007_0
crossref_primary_10_3390_molecules25173936
crossref_primary_10_1186_s13033_020_00433_z
crossref_primary_10_1007_s40203_024_00287_0
crossref_primary_10_1007_s00240_023_01503_w
crossref_primary_10_1016_j_rhum_2017_12_009
crossref_primary_10_1080_21642850_2022_2146585
crossref_primary_10_1016_j_compbiolchem_2023_107826
crossref_primary_10_1016_j_phyplu_2023_100508
crossref_primary_10_1007_s13205_021_02745_4
crossref_primary_10_1093_inthealth_ihz063
crossref_primary_10_3390_ph17121600
crossref_primary_10_7759_cureus_62192
crossref_primary_10_1080_17441692_2023_2191687
crossref_primary_10_1186_s12906_023_03972_3
crossref_primary_10_52711_0974_360X_2024_00207
crossref_primary_10_1080_10130950_2019_1707000
crossref_primary_10_18052_www_scipress_com_IJPPE_13_45
crossref_primary_10_1002_14651858_CD013391
Cites_doi 10.1136/bmj.315.7100.115
10.1097/NMD.0b013e3181a61dbc
10.1016/j.healthpol.2010.04.006
10.1093/ije/dys210
10.7314/APJCP.2013.14.6.3593
10.4103/0019-557X.119818
10.1016/S1470-2045(14)70029-4
10.1016/j.socscimed.2012.05.032
10.1016/j.aogh.2014.04.013
10.1016/j.healthpol.2004.05.008
10.2471/BLT.07.042820
10.1057/jphp.2011.26
10.1016/S0140-6736(09)61261-7
10.1136/bmj.f4145
10.1192/bjp.183.4.349
10.1093/heapol/czs010
10.1016/j.jep.2012.07.017
10.3389/fphar.2013.00177
10.1186/s12913-014-0560-y
10.1097/00002030-199702000-00013
10.1186/1472-6882-14-504
10.1186/1746-4269-7-39
ContentType Journal Article
Copyright The Author 2016
The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. 2016
The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
Copyright_xml – notice: The Author 2016
– notice: The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. 2016
– notice: The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
DBID TOX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7T2
7TQ
8BJ
C1K
DHY
DON
FQK
JBE
K9.
7X8
5PM
DOI 10.1093/heapol/czw022
DatabaseName Oxford Journals Open Access (Activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
Health and Safety Science Abstracts (Full archive)
PAIS Index
International Bibliography of the Social Sciences (IBSS)
Environmental Sciences and Pollution Management
PAIS International
PAIS International (Ovid)
International Bibliography of the Social Sciences
International Bibliography of the Social Sciences
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
International Bibliography of the Social Sciences (IBSS)
Applied Social Sciences Index and Abstracts (ASSIA)
PAIS International
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Medicine
Geography
EISSN 1460-2237
EndPage 991
ExternalDocumentID PMC5013777
27033366
10_1093_heapol_czw022
10.1093/heapol/czw022
48509160
Genre Journal Article
GeographicLocations Mexico
South Africa
Ghana
China
Russia
India
GeographicLocations_xml – name: South Africa
– name: Mexico
– name: China
– name: Russia
– name: Ghana
– name: India
GrantInformation_xml – fundername: Department of Health
  grantid: WMCLAHRC-2014-1
GroupedDBID ---
-E4
.2P
.I3
.ZR
0R~
18M
1TH
29I
2WC
4.4
482
48X
5GY
5VS
5WA
70D
A8Z
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUQX
AAVAP
AAWTL
AAZDW
ABBHK
ABEJV
ABEUO
ABGNP
ABIVO
ABIXL
ABKDP
ABLJU
ABNKS
ABPQP
ABPTD
ABQLI
ABWST
ABXSQ
ABXVV
ABYLZ
ABZBJ
ACGFO
ACGFS
ACHQT
ACPRK
ACUFI
ACUTJ
ACUTO
ACVHY
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADMHG
ADOCK
ADQBN
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AFFZL
AFIYH
AFOFC
AFRAH
AGINJ
AGKEF
AGQXC
AGQZG
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AILCM
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
AMHCJ
AMNDL
APIBT
APWMN
AXUDD
BAWUL
BAYMD
BEYMZ
BHONS
BTRTY
BVRKM
BWUDY
C45
CDBKE
CNZYI
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
F5P
F9B
FLUFQ
FOEOM
FOTVD
FQBLK
FTKQU
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
JENOY
JKPJF
JPL
JPM
JST
JVCUD
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
MS~
N9A
NGC
NOMLY
NOYVH
NPJNY
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OPAEJ
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROZ
RPM
RUSNO
RW1
RXO
SA0
SV3
TJX
TMA
TOX
TR2
W8F
WH7
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
53G
AAPGJ
AAWDT
ABNGD
ABQTQ
ABSMQ
ACFRR
ACPQN
ACUKT
ADMTO
ADPDF
AEAAH
AEHUL
AEKPW
AFSHK
AFYAG
AGKRT
APJGH
AQDSO
AQKUS
ASPBG
ATTQO
AVWKF
AZFZN
BZKNY
C1A
CAG
COF
EGZRM
EIHJH
FEDTE
GROUPED_DOAJ
HVGLF
M49
MBLQV
NTWIH
NU-
O0~
OBFPC
O~Y
PB-
PMFND
QBD
RIG
RNI
RZF
RZO
YHZ
~OX
~OY
~P0
AAYXX
AGQPQ
AHGBF
CITATION
PMKZF
PVKVW
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7T2
7TQ
8BJ
C1K
DHY
DON
FQK
JBE
K9.
7X8
5PM
ID FETCH-LOGICAL-c503t-6cf0fad8cee0ebf782606cb64e90df5829d6f003a96b452ba3ceae45c97ec9703
IEDL.DBID TOX
ISSN 0268-1080
1460-2237
IngestDate Thu Aug 21 18:15:10 EDT 2025
Fri Jul 11 08:19:37 EDT 2025
Mon Jun 30 07:45:57 EDT 2025
Mon Jul 21 05:51:14 EDT 2025
Tue Jul 01 01:15:50 EDT 2025
Thu Apr 24 22:57:05 EDT 2025
Wed Apr 02 07:02:01 EDT 2025
Thu Jun 19 22:29:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Medicine
traditional
health policy
World Health Organization
developing countries
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c503t-6cf0fad8cee0ebf782606cb64e90df5829d6f003a96b452ba3ceae45c97ec9703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://dx.doi.org/10.1093/heapol/czw022
PMID 27033366
PQID 2431016773
PQPubID 34190
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5013777
proquest_miscellaneous_1818332173
proquest_journals_2431016773
pubmed_primary_27033366
crossref_citationtrail_10_1093_heapol_czw022
crossref_primary_10_1093_heapol_czw022
oup_primary_10_1093_heapol_czw022
jstor_primary_48509160
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-10-01
PublicationDateYYYYMMDD 2016-10-01
PublicationDate_xml – month: 10
  year: 2016
  text: 2016-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Health policy and planning
PublicationTitleAlternate Health Policy Plan
PublicationYear 2016
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References 2016090705530080000_31.8.984.30
2016090705530080000_31.8.984.29
2016090705530080000_31.8.984.28
2016090705530080000_31.8.984.23
2016090705530080000_31.8.984.21
2016090705530080000_31.8.984.20
2016090705530080000_31.8.984.27
2016090705530080000_31.8.984.26
2016090705530080000_31.8.984.25
2016090705530080000_31.8.984.24
2016090705530080000_31.8.984.5
2016090705530080000_31.8.984.4
2016090705530080000_31.8.984.3
2016090705530080000_31.8.984.2
2016090705530080000_31.8.984.9
2016090705530080000_31.8.984.7
2016090705530080000_31.8.984.6
Peltzer (2016090705530080000_31.8.984.22) 2009; 374
Ekor (2016090705530080000_31.8.984.8) 2014; 4
2016090705530080000_31.8.984.19
2016090705530080000_31.8.984.18
2016090705530080000_31.8.984.17
2016090705530080000_31.8.984.12
2016090705530080000_31.8.984.34
2016090705530080000_31.8.984.11
2016090705530080000_31.8.984.33
2016090705530080000_31.8.984.10
2016090705530080000_31.8.984.32
2016090705530080000_31.8.984.31
2016090705530080000_31.8.984.1
Mbatha (2016090705530080000_31.8.984.16) 2012; 102(3 Pt 1)
2016090705530080000_31.8.984.15
2016090705530080000_31.8.984.14
2016090705530080000_31.8.984.13
References_xml – ident: 2016090705530080000_31.8.984.11
  doi: 10.1136/bmj.315.7100.115
– ident: 2016090705530080000_31.8.984.26
  doi: 10.1097/NMD.0b013e3181a61dbc
– volume: 102(3 Pt 1)
  start-page: 129
  year: 2012
  ident: 2016090705530080000_31.8.984.16
  article-title: Sick certificates issued by South African traditional health practitioners: current legislation, challenges and the way forward
  publication-title: South African Medical Journal (Suid-Afrikaanse tydskrif vir geneeskunde
– ident: 2016090705530080000_31.8.984.5
– ident: 2016090705530080000_31.8.984.31
  doi: 10.1016/j.healthpol.2010.04.006
– ident: 2016090705530080000_31.8.984.7
– ident: 2016090705530080000_31.8.984.34
– ident: 2016090705530080000_31.8.984.32
– ident: 2016090705530080000_31.8.984.30
– ident: 2016090705530080000_31.8.984.1
– ident: 2016090705530080000_31.8.984.15
  doi: 10.1093/ije/dys210
– ident: 2016090705530080000_31.8.984.18
  doi: 10.7314/APJCP.2013.14.6.3593
– ident: 2016090705530080000_31.8.984.10
  doi: 10.4103/0019-557X.119818
– ident: 2016090705530080000_31.8.984.9
  doi: 10.1016/S1470-2045(14)70029-4
– ident: 2016090705530080000_31.8.984.23
  doi: 10.1016/j.socscimed.2012.05.032
– ident: 2016090705530080000_31.8.984.25
  doi: 10.1016/j.aogh.2014.04.013
– ident: 2016090705530080000_31.8.984.27
  doi: 10.1016/j.healthpol.2004.05.008
– ident: 2016090705530080000_31.8.984.28
  doi: 10.2471/BLT.07.042820
– ident: 2016090705530080000_31.8.984.29
– ident: 2016090705530080000_31.8.984.21
  doi: 10.1057/jphp.2011.26
– volume: 374
  start-page: 956
  year: 2009
  ident: 2016090705530080000_31.8.984.22
  article-title: Traditional health practitioners in South Africa
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(09)61261-7
– ident: 2016090705530080000_31.8.984.13
  doi: 10.1136/bmj.f4145
– ident: 2016090705530080000_31.8.984.33
– ident: 2016090705530080000_31.8.984.19
– ident: 2016090705530080000_31.8.984.20
  doi: 10.1192/bjp.183.4.349
– ident: 2016090705530080000_31.8.984.24
  doi: 10.1093/heapol/czs010
– ident: 2016090705530080000_31.8.984.2
– ident: 2016090705530080000_31.8.984.3
  doi: 10.1016/j.jep.2012.07.017
– volume: 4
  start-page: 177
  year: 2014
  ident: 2016090705530080000_31.8.984.8
  article-title: The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
  publication-title: Frontiers in Pharmacology
  doi: 10.3389/fphar.2013.00177
– ident: 2016090705530080000_31.8.984.12
– ident: 2016090705530080000_31.8.984.4
  doi: 10.1186/s12913-014-0560-y
– ident: 2016090705530080000_31.8.984.14
  doi: 10.1097/00002030-199702000-00013
– ident: 2016090705530080000_31.8.984.17
  doi: 10.1186/1472-6882-14-504
– ident: 2016090705530080000_31.8.984.6
  doi: 10.1186/1746-4269-7-39
SSID ssj0014445
Score 2.5740275
Snippet It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to...
SourceID pubmedcentral
proquest
pubmed
crossref
oup
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 984
SubjectTerms Access
Adult
Aged
Arthritis
Cataracts
Chronic conditions
Chronic Disease
Chronic illnesses
Developing Countries
Diabetes
Diabetes mellitus
Female
Geography
Health care
Health care policy
Health education
Health needs
Health Policy
Health services
Health Surveys
Humans
Hypertension
Income
Low income groups
Male
Medicine
Medicine, Traditional - statistics & numerical data
Middle Aged
Multivariate analysis
Original
ORIGINAL ARTICLES
Policy making
Populations
Rural areas
Rural Population
Rural schools
Rurality
Socioeconomic Factors
Traditional medicine
World Health Organization
Subtitle a WHO-SAGE study
Title Use of traditional medicine in middle-income countries
URI https://www.jstor.org/stable/48509160
https://www.ncbi.nlm.nih.gov/pubmed/27033366
https://www.proquest.com/docview/2431016773
https://www.proquest.com/docview/1818332173
https://pubmed.ncbi.nlm.nih.gov/PMC5013777
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA-ykyDit_OLCOLJYmg-mnoTcRRBd3G4W0naBAfaDbsh-Nf7knTFTUUP7SUvaXkvyfvK-wWhs9KlilSqI6Y5vKiWkVZERqXVxBJoKEpXKHz_ILIBuxvyYRPvqH9I4af0Ejalyfjlsvh4B30Dmy0oYAeS_9gftukCxvxtxOBPOKxSSRowzW-9F5RPOH-4VNj2xb5cPib5Re_0NtB6YzDi6yDhTbRiqi20FqJtOBQRbaNsUBs8thgGKEchuofnWXM8qvCrD0NEDonh1WB_P4Rzka-wwk9ZP3JpJeyBZnfQoHf7eJNFzR0JUcEJnUaisMSqUoKuI0Zb0PfgkRRaMJOS0nIZp6WwsHJVKjTjsVa0MMowXqSJgYfQXdSpxpXZR1jF4OpJZjVPDNPCamcaEgfebXlKjeyiiznz8qIBEHf3WLzkIZFN88DrPPC6i85b8klAzviNcNdLoqVi0lkxgnTRKYjmr85Hc8Hlzeqr8xisIldekVAYom2GdeOSIaoy41mdg2UjKQWHDGj2gpzbL8XAF0qF6KJkYQa0BA6Te7GlGj17bG7uIRyTg3_8-iFaBetLhJOBR6gzfZuZY7BwpvrEB51O_Bz_BKZc_Qk
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+traditional+medicine+in+middle-income+countries%3A+a+WHO-SAGE+study&rft.jtitle=Health+policy+and+planning&rft.au=Oyebode%2C+Oyinlola&rft.au=Kandala%2C+Ngianga-Bakwin&rft.au=Chilton%2C+Peter+J&rft.au=Lilford%2C+Richard+J&rft.date=2016-10-01&rft.pub=Oxford+University+Press&rft.issn=0268-1080&rft.eissn=1460-2237&rft.volume=31&rft.issue=8&rft.spage=984&rft.epage=991&rft_id=info:doi/10.1093%2Fheapol%2Fczw022&rft_id=info%3Apmid%2F27033366&rft.externalDocID=PMC5013777
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1080&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1080&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1080&client=summon